Vimarsana
Biggest News Aggregation in the World

Page 16 - Master File News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Master File. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Master File Today - Breaking & Trending Today

Transfer Pricing Regulations in India: An Overview - Vimarsana News

Transfer Pricing Regulations in India: An Overview

We introduce the transfer pricing regulations in India, including the master file and CbCR requirements. This article is part one of a four-part series.

Izgleda da su Epsteina i Gatesa povezali mlada znanstvenica i hrvatski znanstvenik - Vimarsana News

Izgleda da su Epsteina i Gatesa povezali mlada znanstvenica i hrvatski znanstvenik

BILLA Gatesa i Jeffreyja Epsteina povezali su američka neuroznanstvenica i hrvatski imunolog, piše Rolling Stone.

Source: index.hr
Bharat Biotech's US partner, Ocugen to apply for full approval for Covaxin - Vimarsana News

Bharat Biotech's US partner, Ocugen to apply for full approval for Covaxin

Pennsylvania [US], June 11 (ANI): Bharat Biotech's US partner Ocugen Inc said that the company will no longer pursue an Emergency Use Authorization (EUA) for COVAXIN and the US Food and Drug Administration (FDA) has recommended that the company go for the Biologics Licence Application (BLA) route, which is for full approval, with additional data.

Source: aninews.in
US FDA rejects emergency use approval for Bharat Biotech's Covaxin - Vimarsana News

US FDA rejects emergency use approval for Bharat Biotech's Covaxin

Bharat Biotech's US partner Ocugen said it would no longer seek emergency approval for Covaxin, and would rather file for full approval of the anti-COVID shot

Source: msn.com
US FDA Denies Covaxin Emergency Use Approval - The Wire Science - Vimarsana News

US FDA Denies Covaxin Emergency Use Approval - The Wire Science

The FDA's verdict is the second roadblock Bharat Biotech has faced with respect to rolling Covaxin out in other parts of the world.